Healthcare Interoperability Solutions Market Status (2016-2020) and Forecast Market Analysis, Regional Outlook, Segment Growth Potential, and Competitive Market Share Analysis, 2021-2027
Report Description
The global Healthcare Interoperability Solutions market size is estimated at USD 2,809.6 million in 2020, expanding at a CAGR 6.6% from 2021-2027 to reach 5,800.6 Million USD in 2027.
Market Dynamics
Increased deployment of interoperability alternatives by hospital officials, increased securities to strengthen health services, government incentives proposals to strengthen clinical outcomes, elevated federal fundraising, and emphasis on acute management are among the significant variables driving industry development. Moreover, by enabling real-time accessibility to information, interoperability is predicted to lower the aggregate cost of postponed diagnosis and therapy. Nevertheless, the rise in complication as a result of a shortage of trustworthy data, as well as confidentiality issues, are a handful of other important issues that are likely to hamper the implementation of interoperability options in the near term throughout the projection timeframe.
The necessity of distant diagnostics, treatment, and consulting has been reinforced by COVID-19. Nevertheless, because numerous healthcare professionals are already concentrating on videoconference and phone conversations, this industry is expected to grow multiple folds during the following years. Clients with mild complaints were also required to counsel online under the social separation techniques. COVID 19 is projected to have a substantial influence on the medical interoperability solutions industry as a result of these considerations.
Regional Insights
The Hospital Interoperability Solutions market is segmented into four regions: Europe, North America, Asia Pacific, and the Rest of the World. Throughout the projected timeline, the Asia Pacific industry is expected to develop at the fastest CAGR. Expanding government proposals for electronic health records, growing health travel industry, surging demand for value health coverage, as well as the expanding need for the deployment and incorporation of healthcare gadgets and HCIT alternatives to offer premium as well as efficient treatment to clients are driving industry expansion in the region.
The Healthcare Interoperability Solutions market is classified into four categories: type, level, deployment, and end-user. Depending on levels, structural interoperability seemed to have the biggest industry share because of the widespread deployment of technologies including e-prescribing, in which practitioners and pharmacies utilize the same information. The healthcare practitioners category is predicted to have the greatest CAGR throughout the projection period. Increased customer volume, there is a need to contain growing medical expenses, and federal requirements are driving the expansion of this market.
Competitive Insights
The Healthcare Interoperability Solutions industry is extremely fragmented, with both domestic and foreign competitors present. To maintain competitiveness, key firms in the business participate in planned mergers and acquisitions, partnerships, and innovative product releases. For example, InterSystems Company joined with Oncodesign in May 2021. During this collaboration, Oncodesign will employ InterSystems' IRIS for Medical nursing scheme to manage and exploit hospital information in order to speed the discovery of innovative cancer therapies using AI.
The report begins with an overview of the Industry Chain structure, and describes the industry environment, then analyses market size and forecast of Healthcare Interoperability Solutions by type, region, End-Use, level, and deployment. In addition, this report introduces the market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
- Allscripts Healthcare Solutions, Inc.
- Cerner Corporation
- Epic Systems Corporation
- IBM Watson Health
- Infor, Inc.
- Interfaceware Inc.
- InterSystems Corporation
- Jitterbit
- Koninklijke Philips NV
- MphRx, Inc
- Nalashaa Healthcare
- Nextgen Healthcare, Inc.
- NXGN Management, LLC
- Orion Health Group Limited
- OSP Labs
- Virtusa Corp.
- Visolve Inc.
Type Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):
- Lab system interoperability
- EHR interoperability
- Healthcare information exchange interoperability
- Imaging system interoperability
- Enterprise interoperability
- Others
Level Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):
- Foundational
- Structural
- Semantic
Deployment Coverage (Market Size & Forecast, Main Consumer Analysis etc.):
- Cloud Based
- On Premise
End-Use Coverage (Market Size & Forecast, Main Consumer Analysis etc.):
- Healthcare Providers
- Healthcare Payers
- Pharmacies
Region Coverage (Regional Consumption, Demand & Forecast by Countries etc.):
- North America (U.S., and Canada)
- Europe (Germany, U.K., France, Italy, Spain etc.)
- Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
- South America (Brazil, Mexico, Argentina etc.)
- Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)
Table Of Content
1. Healthcare Interoperability Solutions Market Overview
1.1. Product Overview and Scope of Healthcare Interoperability Solutions
1.2. Global Market Growth Prospects and Revenue Estimates
1.3. Global Healthcare Interoperability Solutions Market Size Growth Rate Analysis by Type 2020 VS 2027
1.3.1. Lab system interoperability
1.3.2. EHR interoperability
1.3.3. Healthcare information exchange interoperability
1.3.4. Imaging system interoperability
1.3.5. Enterprise interoperability
1.3.6. Others
1.4. Global Healthcare Interoperability Solutions Consumption Comparison by Level: 2020 VS 2027
1.4.1. Foundational
1.4.2. Structural
1.4.3. Semantic
1.5. Global Healthcare Interoperability Solutions Consumption Comparison by End-User: 2020 VS 2027
1.5.1. Healthcare Providers
1.5.2. Healthcare Payers
1.5.3. Pharmacies
1.6. Global Healthcare Interoperability Solutions Consumption Comparison by Deployment: 2020 VS 2027
1.6.1. Cloud Based
1.6.2. On Premise
1.7. Global Healthcare Interoperability Solutions Market Size Estimates and Forecasts by Region: 2020 VS 2027
1.7.1. North America Healthcare Interoperability Solutions Estimates
1.7.2. Europe Healthcare Interoperability Solutions Estimates
1.7.3. China Healthcare Interoperability Solutions Estimates
1.7.4. Japan Healthcare Interoperability Solutions Estimates
2. Market Competition by Manufacturers
2.1. Global Healthcare Interoperability Solutions Revenue Market Share by Manufacturers (2020)
2.2. Healthcare Interoperability Solutions Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3. Global Healthcare Interoperability Solutions Average Price by Manufacturers (2016-2021)
2.4. Manufacturers Healthcare Interoperability Solutions Production Sites, Area Served, Product Types
2.5. Healthcare Interoperability Solutions Market Competitive Situation and Trends
2.5.1. Healthcare Interoperability Solutions Market Concentration Rate
2.5.2. Mergers & Acquisitions, Expansion
3. Global Healthcare Interoperability Solutions Consumption by Region (2016-2021)
3.1. Global Healthcare Interoperability Solutions Consumption by Region
3.2. Global Healthcare Interoperability Solutions Consumption Market Share by Region
3.2.1. North America
3.2.2. North America Healthcare Interoperability Solutions Consumption Growth Rate (2016-2021)
3.2.3. North America Healthcare Interoperability Solutions Consumption, Price and Gross Margin (2016-2021)
3.2.4. North America Healthcare Interoperability Solutions Consumption by Country
3.2.4.1. U.S.
3.2.4.2. Canada
3.2.5. Europe
3.2.6. Europe Healthcare Interoperability Solutions Consumption Growth Rate (2016-2021)
3.2.7. Europe Healthcare Interoperability Solutions Consumption, Price and Gross Margin (2016-2021)
3.2.8. Europe Healthcare Interoperability Solutions Consumption by Country
3.2.8.1. Germany
3.2.8.2. U.K.
3.2.8.3. France
3.2.8.4. Italy
3.2.8.5. Spain
3.2.9. Asia Pacific
3.2.10. Asia Pacific Healthcare Interoperability Solutions Consumption Growth Rate (2016-2021)
3.2.11. Asia Pacific Healthcare Interoperability Solutions Consumption, Price and Gross Margin (2016-2021)
3.2.12. Asia Pacific Healthcare Interoperability Solutions Consumption by Country
3.2.12.1. China
3.2.12.2. India
3.2.12.3. Japan
3.2.12.4. Indonesia
3.2.12.5. Malaysia
3.2.12.6. Australia
3.2.12.7. South Korea
3.2.13. South America
3.2.14. South America Healthcare Interoperability Solutions Consumption Growth Rate (2016-2021)
3.2.15. South America Healthcare Interoperability Solutions Consumption, Price and Gross Margin (2016-2021)
3.2.16. South America Healthcare Interoperability Solutions Consumption by Country
3.2.16.1. Brazil
3.2.16.2. Mexico
3.2.16.3. Argentina
3.2.17. Middle East and Africa
3.2.18. Middle East and Africa Healthcare Interoperability Solutions Consumption Growth Rate (2016-2021)
3.2.19. Middle East and Africa Healthcare Interoperability Solutions Consumption, Price and Gross Margin (2016-2021)
3.2.20. Middle East and Africa Healthcare Interoperability Solutions Consumption by Country
3.2.20.1. Saudi Arabia
3.2.20.2. Kuwait
3.2.20.3. UAE
3.2.20.4. South Africa
4. Global Healthcare Interoperability Solutions Consumption by Type (2016-2021)
4.1. Global Healthcare Interoperability Solutions Price by Type (2016-2021)
4.2. Global Healthcare Interoperability Solutions Revenue Market Share by Type (2016-2021)
4.2.1. Lab system interoperability
4.2.2. EHR interoperability
4.2.3. Healthcare information exchange interoperability
4.2.4. Imaging system interoperability
4.2.5. Enterprise interoperability
4.2.6. Others
5. Global Healthcare Interoperability Solutions Consumption by Level (2016-2021)
5.1. Global Healthcare Interoperability Solutions Price by Level (2016-2021)
5.2. Global Healthcare Interoperability Solutions Revenue Market Share by Level (2016-2021)
5.2.1. Foundational
5.2.2. Structural
5.2.3. Semantic
6. Global Healthcare Interoperability Solutions Consumption by End-User (2016-2021)
6.1. Global Healthcare Interoperability Solutions Price by End-User (2016-2021)
6.2. Global Healthcare Interoperability Solutions Revenue Market Share by End-User (2016-2021)
6.2.1. Healthcare Providers
6.2.2. Healthcare Payers
6.2.3. Pharmacies
7. Global Healthcare Interoperability Solutions Consumption by Deployment (2016-2021)
7.1. Global Healthcare Interoperability Solutions Price by Deployment (2016-2021)
7.2. Global Healthcare Interoperability Solutions Revenue Market Share by Deployment (2016-2021)
7.2.1. Cloud Based
7.2.2. On Premise
8. Key Companies Profiled
8.1. Allscripts Healthcare Solutions, Inc.
8.1.1. Allscripts Healthcare Solutions, Inc. Healthcare Interoperability Solutions Corporation Information
8.1.2. Allscripts Healthcare Solutions, Inc. Healthcare Interoperability Solutions Product Portfolio
8.1.3. Allscripts Healthcare Solutions, Inc. Healthcare Interoperability Solutions Consumption, Price and Gross Margin (2016-2021)
8.1.4. Allscripts Healthcare Solutions, Inc. Main Business and Markets Served
8.1.5. Allscripts Healthcare Solutions, Inc. Recent Developments/Updates
8.2. Allscripts Healthcare Solutions, Inc.
8.3. Cerner Corporation
8.4. Epic Systems Corporation
8.5. IBM Watson Health
8.6. Infor, Inc.
8.7. Interfaceware Inc.
8.8. InterSystems Corporation
8.9. Jitterbit
8.10. Koninklijke Philips NV
8.11. MphRx, Inc
8.12. Nalashaa Healthcare
8.13. Nextgen Healthcare, Inc.
8.14. NXGN Management, LLC
8.15. Orion Health Group Limited
8.16. OSP Labs
8.17. Virtusa Corp.
8.18. Visolve Inc.
9. Marketing Channel, Distributors and Customers
9.1. Marketing Channel
9.2. Healthcare Interoperability Solutions Distributors List
9.3. Healthcare Interoperability Solutions Customers
10. Market Dynamics
10.1. Healthcare Interoperability Solutions Industry Trends
10.2. Healthcare Interoperability Solutions Growth Drivers
10.3. Healthcare Interoperability Solutions Market Challenges
10.4. Healthcare Interoperability Solutions Market Restraints
11. Global Healthcare Interoperability Solutions Consumption and Demand Forecast, by Region (2022-2027)
11.1. Global Forecasted Demand Analysis of Healthcare Interoperability Solutions, by Regions and Country
11.1.1. North America Forecasted Consumption of Healthcare Interoperability Solutions by Country
11.1.2. Europe Market Forecasted Consumption of Healthcare Interoperability Solutions by Country
11.1.3. Asia Pacific Market Forecasted Consumption of Healthcare Interoperability Solutions by Region
11.1.4. Latin America Forecasted Consumption of Healthcare Interoperability Solutions by Country
11.1.5. Middle East and Africa Forecasted Consumption of Healthcare Interoperability Solutions by Country
12. Global Healthcare Interoperability Solutions Consumption and Demand Forecast, by Device Segments (2022-2027)
12.1. Global Forecasted Consumption of Healthcare Interoperability Solutions by Device Segments (2022-2027)
12.2. Global Consumption and Price Forecast by Device Segments (2022-2027)
12.3. Global Forecasted Growth Rate of Healthcare Interoperability Solutions by Device Segments (2022-2027)
13. Research Finding and Conclusion
14. Methodology and Data Source
14.1. Methodology/Research Approach
14.1.1. Research Programs/Type
14.1.2. Market Size Estimation
14.1.3. Market Breakdown and Data Triangulation
14.2. Data Source
14.2.1. Secondary Sources
14.2.2. Primary Sources
14.3. Author List
14.4. Disclaimer
Research Methodology
Our research studies are primarily performed in five phases which include Secondary Research, Primary Research, Subject Matter Expert Advice, Quality Check, and Final Review. The process opted for conducting thorough research to make authentic business reports is briefly described below-
Secondary Research-
- Based on the understanding of requirements, we conducted secondary research to identify the Segment specifications, qualitative and quantitative data along with the factors responsible for the growth of the market.
- The secondary sources referred for the study include press releases, company annual reports, and research papers related to the industry.
- Various sources such as industry magazines, trade journals, government websites, and associations were also reviewed for gathering precise analysis on opportunities for business expansions in the market.
- Moreover, quantitative as well as qualitative data were also extracted from paid databases, which included Reuters, Factiva, Bloomberg, One Source, and Hoovers, which proved to be useful for in-depth technical study of the market.
Primary Research-
- The research carried out during the desk research was verified by primary interviews. Primary research was scheduled with a number of industry experts for conducting telephonic interviews, and also our team send questionnaires through their official emails.
- The secondary data collected was then verified by various industry participants which included Segment managers, marketing managers, VPs, CEOs, purchasing managers, subject matter experts.
- An interview with the mentioned participants aids invalidation of our research findings regarding the Segment.
- It helps in the provision of first-hand data on factors such as market size, growth, regional trends, market trends, and competition in the industry. This approach makes our findings precise in order to help our clients in strategic decision-making processes.
Subject Matter Advice-
- The secondary and primary research key findings were then validated by the in-house subject matter experts having extensive experience in the market research industry.
- Specific requirements of the clients were reviewed by the experts to check for completion of the market study. Experts help in channelizing the representation skills of the analyst in terms of providing data that can be easily understood by our customers.
Quality Check-
- The analysis done by the research team was further reviewed to check for data accuracy provided to suit the clients’ specific requirements.
- This revision was done in various phases to check the data authenticity and to remove negligible errors in the final compilation.
Final Review-
- After the quality check, a final review of the report was done to look after the presentation, formatting, and to recheck if all the requirements of the clients were addressed. The next phase remains dispatch of the report to the client.
Enquire Before Purchase
Frequently Asked Questions
Why Choose Market Research Strategy?
We utilize market analysis/information from verified authenticated data sources to scoop accurate research reports
We understand the urgency of our clients and their clients' in the competitive space thus, deliver the report in minimum turnaround
Without further ado, choose us and get instant access to reliable analysis to help you make the right business decisions.
We abide by the information security policy and adheres to keep your private and business information confidential and secure.